U.S. markets close in 1 hour
  • S&P 500

    3,850.94
    +9.00 (+0.23%)
     
  • Dow 30

    31,989.48
    +493.18 (+1.57%)
     
  • Nasdaq

    12,719.01
    -201.13 (-1.56%)
     
  • Russell 2000

    2,210.00
    +17.79 (+0.81%)
     
  • Crude Oil

    64.81
    -1.28 (-1.94%)
     
  • Gold

    1,680.20
    -18.30 (-1.08%)
     
  • Silver

    25.25
    -0.04 (-0.17%)
     
  • EUR/USD

    1.1861
    -0.0064 (-0.53%)
     
  • 10-Yr Bond

    1.5940
    +0.0400 (+2.57%)
     
  • GBP/USD

    1.3838
    +0.0010 (+0.07%)
     
  • USD/JPY

    108.8660
    +0.4840 (+0.45%)
     
  • BTC-USD

    51,329.91
    +819.04 (+1.62%)
     
  • CMC Crypto 200

    1,040.47
    +16.26 (+1.59%)
     
  • FTSE 100

    6,719.13
    +88.61 (+1.34%)
     
  • Nikkei 225

    28,743.25
    -121.07 (-0.42%)
     

Vertex Pharmaceuticals Inc (VRTX) EVP, Global Research and CSO David Altshuler Sold $1. ...

GuruFocus.com
·2 min read

- By insider

EVP, Global Research and CSO of Vertex Pharmaceuticals Inc (30-Year Financial, Insider Trades) David Altshuler (insider trades) sold 7,825 shares of VRTX on 02/18/2021 at an average price of $211.83 a share. The total sale was $1.7 million.


Vertex Pharmaceuticals Inc is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases in specialty markets. Its products include SYMDEKO, ORKAMBI, and KALYDECO. Vertex Pharmaceuticals Inc has a market cap of $53.82 billion; its shares were traded at around $207.020000 with a P/E ratio of 20.09 and P/S ratio of 8.79.

Directors and Officers Recent Trades:

  • SVP & Chief Accounting Officer Paul M Silva sold 4,295 shares of VRTX stock on 02/18/2021 at the average price of $211.83. The price of the stock has decreased by 2.27% since.

  • EVP, Chief Patient Officer Amit Sachdev sold 9,264 shares of VRTX stock on 02/18/2021 at the average price of $211.83. The price of the stock has decreased by 2.27% since.

  • EVP, Chief Adm, Leg & BD Off Michael Parini sold 7,825 shares of VRTX stock on 02/18/2021 at the average price of $211.83. The price of the stock has decreased by 2.27% since.

  • EVP, Chief Commercial Officer Stuart A Arbuckle sold 7,825 shares of VRTX stock on 02/18/2021 at the average price of $211.82. The price of the stock has decreased by 2.27% since.

  • EVP, Global Research and CSO David Altshuler sold 7,825 shares of VRTX stock on 02/18/2021 at the average price of $211.83. The price of the stock has decreased by 2.27% since.

For the complete insider trading history of VRTX, click here

.This article first appeared on GuruFocus.